[go: up one dir, main page]

AR056721A1 - Preparado farmaceutico oral estabilizado que contiene clopidogrel bisulfato - Google Patents

Preparado farmaceutico oral estabilizado que contiene clopidogrel bisulfato

Info

Publication number
AR056721A1
AR056721A1 ARP060104644A ARP060104644A AR056721A1 AR 056721 A1 AR056721 A1 AR 056721A1 AR P060104644 A ARP060104644 A AR P060104644A AR P060104644 A ARP060104644 A AR P060104644A AR 056721 A1 AR056721 A1 AR 056721A1
Authority
AR
Argentina
Prior art keywords
bisulfato
oral pharmaceutical
pharmaceutical containing
stabilized oral
containing clopidogrel
Prior art date
Application number
ARP060104644A
Other languages
English (en)
Inventor
Joon Gyo Oh
Dong-Chul Shin
Ji Young Shin
Won-No Youn
Key An Um
Dong-Sun Min
Jae-Sun Kim
Nam Ho Kim
Nam Kyu Lee
Original Assignee
Sk Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sk Chemicals Co Ltd filed Critical Sk Chemicals Co Ltd
Publication of AR056721A1 publication Critical patent/AR056721A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Preparado oral estabilizado que incluye clopidogrel bisulfato, y en particular el presente preparado oral comprende además almidon y celulosa junto con la forma cristalina 1 o forma cristalina 2 de clopidogrel bisulfato, que es sensible a la humedad y produce impurezas relacionadas con productos hidratados cuando se formula en preparados orales, mostrando así estabilidad al almacenamiento incluso con la misma forma galénica que los preparados convencionales.
ARP060104644A 2005-10-24 2006-10-24 Preparado farmaceutico oral estabilizado que contiene clopidogrel bisulfato AR056721A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020050100460A KR20070044323A (ko) 2005-10-24 2005-10-24 보관안정성이 개선된 클로피도그렐 황산수소염 함유 경구용제제

Publications (1)

Publication Number Publication Date
AR056721A1 true AR056721A1 (es) 2007-10-17

Family

ID=37967949

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060104644A AR056721A1 (es) 2005-10-24 2006-10-24 Preparado farmaceutico oral estabilizado que contiene clopidogrel bisulfato

Country Status (4)

Country Link
KR (1) KR20070044323A (es)
AR (1) AR056721A1 (es)
TW (1) TW200727898A (es)
WO (1) WO2007049868A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101633939B1 (ko) * 2007-10-10 2016-06-27 아반토르 퍼포먼스 머티리얼스, 인크. 직접 압축성 고기능성 과립 미세결정 셀룰로스계 부형제, 그의 제조 방법 및 용도
ES2376057T3 (es) 2008-02-26 2012-03-08 Laboratorios Lesvi, S.L. Formulaciones farmacéuticas que contienen clopidogrel.
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CN109528669A (zh) * 2018-12-25 2019-03-29 哈尔滨珍宝制药有限公司 硫酸氢氯吡格雷组合物、硫酸氢氯吡格雷片剂及其制备方法
CN112999180B (zh) * 2019-12-20 2022-08-30 青岛黄海制药有限责任公司 一种硫酸氢氯吡格雷晶型ⅱ片剂及其制备方法
CN111166745A (zh) * 2020-01-19 2020-05-19 成都施贝康生物医药科技有限公司 含消旋氧吡格雷或其盐的组合物及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792836B3 (fr) * 1999-04-30 2001-07-27 Sanofi Sa Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
CA2363053C (en) * 2001-11-09 2011-01-25 Bernard Charles Sherman Clopidogrel bisulfate tablet formulation
WO2005070464A2 (en) * 2004-01-21 2005-08-04 Biofarma Ilac Sanayi Ve Ticaret A.S. A tablet formulation of clopidogrel bisulphate

Also Published As

Publication number Publication date
WO2007049868A1 (en) 2007-05-03
TW200727898A (en) 2007-08-01
KR20070044323A (ko) 2007-04-27

Similar Documents

Publication Publication Date Title
ECSP088082A (es) Derivados de piridazina
TW200628161A (en) Novel betulin derivatives, preparation thereof and use thereof
ECSP088549A (es) Nuevos derivados de pirrol fusionado
AR072261A1 (es) Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos.
CR9703A (es) Derivados de pirazolona
MY138941A (en) Aryl-pyridine derivatives
TW200626558A (en) Indazolone derivatives
AR064692A1 (es) Derivados de oxindol sustituido medicamentos que los comprenden y uso de los mismos
MX2009010567A (es) Derivados de imidazolidinona.
BRPI0717035B8 (pt) moduladores de benzotriazol cinase
BRPI0408347A (pt) derivados de pirimidina
MX2010005824A (es) Derivados de aminotiazol.
NO20062098L (no) Faststofftilstandmontelukast
ATE520406T1 (de) Kristalline form des ibandronat-natriums
TW200616940A (en) Novel hexafluoroisopropanol substituted ether derivatives
TW200616976A (en) Pyrimidine derivatives
AR056721A1 (es) Preparado farmaceutico oral estabilizado que contiene clopidogrel bisulfato
BRPI0512677A2 (pt) derivados de quinazolina
PA8579301A1 (es) Derivados de tiazol
ATE388695T1 (de) Pharmazeutische zusammensetzung enthaltend ein benzimidazol-derivat gemischt mit mikrokristalliner cellulose
TW200633963A (en) Novel cyclohexane derivatives
MX2009007416A (es) Derivados de sulfonamida como inhibidores de quimasa.
DE60236025D1 (de) Pharmazeutische zusammensetzung enthaltend l-arginin
BR0114156A (pt) Forma amorfa de inibidor de ciclo de célula
BRPI0411087A (pt) aperfeiçoamentos em ou relacionados a compostos orgánicos

Legal Events

Date Code Title Description
FB Suspension of granting procedure